Prognostic effect of hormone receptor status in early HER2 positive breast cancer patients.
Gómez HL, Castañeda CA, Vigil CE, Vidaurre T, Velarde RG, Cruz WR, Pinto JA, Suazo JF, Garcés MR, Neciosup SP, Vallejos CS.
Gómez HL, et al.
Hematol Oncol Stem Cell Ther. 2010;3(3):109-15. doi: 10.1016/s1658-3876(10)50020-7.
Hematol Oncol Stem Cell Ther. 2010.
PMID: 20890067
Free article.